Revvity, Inc. (RVTY)
NYSE: RVTY · Real-Time Price · USD
85.18
-1.62 (-1.87%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Revvity Revenue
In the year 2025, Revvity had annual revenue of $2.86B with 3.67% growth. Revvity had revenue of $772.06M in the quarter ending December 28, 2025, with 5.85% growth.
Revenue (ttm)
$2.86B
Revenue Growth
+3.67%
P/S Ratio
3.33
Revenue / Employee
$259,641
Employees
11,000
Market Cap
9.52B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 28, 2025 | 2.86B | 101.03M | 3.67% |
| Dec 29, 2024 | 2.76B | 4.46M | 0.16% |
| Dec 31, 2023 | 2.75B | -561.25M | -16.95% |
| Jan 1, 2023 | 3.31B | -515.99M | -13.48% |
| Jan 2, 2022 | 3.83B | 1.16B | 43.73% |
| Jan 3, 2021 | Pro | Pro | Pro |
| Dec 29, 2019 | Pro | Pro | Pro |
| Dec 30, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Jan 1, 2017 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Labcorp Holdings | 13.95B |
| Quest Diagnostics | 11.28B |
| ICON Public Limited Company | 8.10B |
| Illumina | 4.34B |
| Charles River Laboratories International | 4.02B |
| Medpace Holdings | 2.68B |
| Qiagen | 2.09B |
| RadNet | 2.04B |
RVTY News
- 22 hours ago - Revvity Transcript: AGM 2026 - Transcripts
- 12 days ago - Revvity to Present at Upcoming Investor Conferences - Business Wire
- 18 days ago - Revvity to Hold Earnings Call on Tuesday, May 5, 2026 - Business Wire
- 19 days ago - Revvity Unveils its Signals BioDesign Offering to Advance Biologic Research Workflows - Business Wire
- 7 weeks ago - Revvity Transcript: Barclays 28th Annual Global Healthcare Conference - Transcripts
- 2 months ago - Revvity Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - Revvity Transcript: 47th Annual Raymond James Institutional Investor Conference - Transcripts
- 2 months ago - Revvity Unveils New High-Impact Discovery Platforms and Showcases Recent Innovations at SLAS2026 - Business Wire